Ventyx Biosciences Statistics
Total Valuation
VTYX has a market cap or net worth of $86.11 million. The enterprise value is -$132.15 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VTYX has 71.16 million shares outstanding. The number of shares has increased by 18.82% in one year.
| Current Share Class | 71.16M |
| Shares Outstanding | 71.16M |
| Shares Change (YoY) | +18.82% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 4.61% |
| Owned by Institutions (%) | 66.24% |
| Float | 54.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 0.92 |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.57, with a Debt / Equity ratio of 0.05.
| Current Ratio | 19.57 |
| Quick Ratio | 18.50 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.04% and return on invested capital (ROIC) is -30.49%.
| Return on Equity (ROE) | -46.04% |
| Return on Assets (ROA) | -29.20% |
| Return on Invested Capital (ROIC) | -30.49% |
| Return on Capital Employed (ROCE) | -56.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.51M |
| Employee Count | 82 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.42% in the last 52 weeks. The beta is 0.73, so VTYX's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -70.42% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 48.72 |
| Average Volume (20 Days) | 1,056,801 |
Short Selling Information
The latest short interest is 7.22 million, so 10.15% of the outstanding shares have been sold short.
| Short Interest | 7.22M |
| Short Previous Month | 7.16M |
| Short % of Shares Out | 10.15% |
| Short % of Float | 13.14% |
| Short Ratio (days to cover) | 5.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -136.78M |
| Pretax Income | -171.30M |
| Net Income | -123.99M |
| EBITDA | -136.48M |
| EBIT | -136.78M |
| Earnings Per Share (EPS) | -$1.75 |
Full Income StatementBalance Sheet
The company has $228.81 million in cash and $10.55 million in debt, giving a net cash position of $218.26 million or $3.07 per share.
| Cash & Cash Equivalents | 228.81M |
| Total Debt | 10.55M |
| Net Cash | 218.26M |
| Net Cash Per Share | $3.07 |
| Equity (Book Value) | 231.63M |
| Book Value Per Share | 3.26 |
| Working Capital | 230.16M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$108.97 million and capital expenditures -$82,000, giving a free cash flow of -$109.05 million.
| Operating Cash Flow | -108.97M |
| Capital Expenditures | -82,000 |
| Free Cash Flow | -109.05M |
| FCF Per Share | -$1.53 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |